3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
10
Myelodysplastic Syndromes
4
Mycoses
4
Hematologic Neoplasms
3
Neoplasms
2
Leukemia
2
Brain Neoplasms
2
Triple Negative Breast Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neutropenia
1
Neoplasm, Residual
1
Myelodysplastic-Myeloproliferative Diseases
1
Leukemia, Myeloid
1
Invasive Fungal Infections
1
Glioma
1
Glioblastoma
1
Genetic Predisposition to Disease
1
Candidiasis
1
Bronchiolitis Obliterans Syndrome
1
Breast Neoplasms
1
Bone Marrow Neoplasms
1
Bone Marrow Failure Disorders
1
Aspergillosis
1
Anemia, Aplastic
1
Interventions
posaconazole
1
liposomal doxorubicin
1
Vinorelbine
1
Surveys and Questionnaires
1
Prophylactic Mastectomy
1
Multiparametric Magnetic Resonance Imaging
1
Minoxidil
1
High-Throughput Nucleotide Sequencing
1
Fluconazole
1
Exome
1
Docetaxel
1
Cephalexin
1
Capecitabine
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Genetic Predisposition to Disease
×
posaconazole
×
Clear all
NCT03828773
2025-12-09
PTX3AML
Centre Hospitalier Universitaire Vaudois
Phase NA
Recruiting
410 enrolled